Poly-Spectrum-8/EX is FDA-approved
Neurosoft proudly announces the approval of its Poly-Spectrum-8/EX ECG systems by the United States Food and Drug Administration (FDA) for marketing in the USA and other countries that recognize FDA approval.
The device will be sold under the trade name CloudEKG by our partner TeleEMG in the United States and other countries recognizing FDA approval to highlight Neurosoft’s pioneering work in leveraging Cloud Technology for it’s medical devices.
We are grateful to everyone involved in making this approval process possible and especially Dr. Joe Jabre, the CEO of TeleEMG and Neurosoft’s partner in the US.
Publication date: May 13, 2014